Skip to content

Welcome to Discover Pharma! Today is : November 10, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Research & Development

  • Clinical & Regulatory,Genomics and sequencing,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas

    Mursla Bio validates liver-specific liquid biopsy platform

    Mursla Bio has published peer-reviewed data showing that isolating liver-derived [...]

    October 13, 2026
  • Biotech & Pharma Business,Digital & Data,Drug Discovery & Development,Research & Development

    Carterra and AstraZeneca target AI-driven drug discovery

    Carterra and AstraZeneca are collaborating to develop laboratory hardware and [...]

    October 12, 2026
  • Biotech & Pharma Business,Research & Development

    Biopharma dealmaking outlook improves despite investor caution

    Biopharma executives expect partnering and mergers and acquisitions to increase [...]

    October 12, 2026
  • Central Nervous System,Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas

    SurVaxM improves survival in Phase 2b glioblastoma trial

    MimiVax’s SurVaxM cancer vaccine improved overall survival in a Phase [...]

    October 12, 2026
  • Research & Development,Therapeutic Areas

    Lab-grown human neuromuscular junctions advance MND drug discovery

    UK biotech Myomaker Bio has developed lab-grown human neuromuscular junctions [...]

    October 7, 2026
  • Clinical & Regulatory,Research & Development

    Olink assay correlates with ELISA for measuring endothelin-1

    A peer-reviewed study has found a significant correlation between Olink [...]

    October 7, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas

    BridgeBio gets FDA Priority Review for oral infigratinib in achondroplasia

    BridgeBio has secured FDA Priority Review for its oral infigratinib [...]

    October 7, 2026
  • Clinical & Regulatory,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas

    ViiV’s Cabenuva achieves superior viral suppression in CROWN Phase 3b study

    ViiV Healthcare’s long-acting HIV treatment Cabenuva achieved superior viral suppression [...]

    October 6, 2026
  • Digital & Data,Drug Discovery & Development,Research & Development

    Shift Bioscience publishes AI virtual cell framework for target discovery

    Shift Bioscience has published research in Nature Biotechnology describing a [...]

    October 6, 2026
  • Clinical & Regulatory,Pharmaceuticals and therapeutics,Research & Development,Therapeutic Areas

    Aravax to present Phase 2 peanut allergy data in November

    Aravax will present topline Phase 2 clinical trial results for [...]

    October 5, 2026
Previous234Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Formation Bio launches $600M drug development fund
    Categories: Biotech & Pharma Business, Drug Discovery & Development, Research & Development
  • ETH Zurich develops electronic implant to lower blood glucose
    Categories: Digital & Data, Drug Discovery & Development, Medical devices, Research & Development, Therapeutic Areas
  • Mineralys reports lorundrostat results in hypertension and kidney disease
    Categories: Clinical & Regulatory, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top